Amygdalin mediates relieved atherosclerosis in apolipoprotein E deficient mice through the induction of regulatory T cells

Biochemical and Biophysical Research Communications

Volumn 411, Issue 3, 2011, Pages 523-529

  Jiagang, Deng ^a   Li, Chunyang ^c   Wang, Hailian ^b   Hao, Erwei ^a   Du, Zhengcai ^a   Bao, Chuanhong ^a   Lv, Jianzhen ^a,c   Wang, Yi ^b,c  

^a GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Amygdalin; Atherosclerosis; Foxp3; Interleukine 10; Regulatory T cells; Transforming growth factor beta

Indexed keywords

AMYGDALIN; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; LAETRILE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA SINUS; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; BLOOD VESSEL PARAMETERS; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOMODULATION; IMMUNOREGULATION; IN VIVO STUDY; LIPOPROTEIN BLOOD LEVEL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

AMYGDALIN; ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; FORKHEAD TRANSCRIPTION FACTORS; LIPIDS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, MUTANT STRAINS; T-LYMPHOCYTES, REGULATORY;

MUS;

EID: 79961129110     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.162     Document Type: Article

References (35)

1. Binder C.J., Chang M.K., Shaw P.X., Miller Y.I., Hartvigsen K., Dewan A., et al. Innate and acquired immunity in atherogenesis. Nat. Med. 2002, 8(11):1218-1226.
2. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352(16):1685-1695.
3. Davenport P., Tipping P.G. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 2003, 163(3):1117-1125.
4. Pinderski L.J., Fischbein M.P., Subbanagounder G., Fishbein M.C., Kubo N., Cheroutre H., et al. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ. Res. 2002, 90(10):1064-1071.
5. Potteaux S., Esposito B., van Oostrom O., Brun V., Ardouin P., Groux H., et al. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 2004, 24(8):1474-1478.
6. Gojova A., Brun V., Esposito B., Cottrez F., Gourdy P., Ardouin P., et al. Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood 2003, 102(12):4052-4058.
7. Mallat Z., Gojova A., Marchiol-Fournigault C., Esposito B., Kamate C., Merval R., et al. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ. Res. 2001, 89(10):930-934.
8. Mallat Z., Ait-Oufella H., Tedgui A. Regulatory T-cell immunity in atherosclerosis. Trends Cardiovasc. Med. 2007, 17(4):113-118.
9. Ait-Oufella H., Salomon B.L., Potteaux S., Robertson A.K., Gourdy P., Zoll J., et al. Natural Tregs control the development of atherosclerosis in mice. Nat. Med. 2006, 12(2):178-180.
10. Mor A., Planer D., Luboshits G., Afek A., Metzger S., Chajek-Shaul T., et al. Role of naturally occurring CD4+CD25+ Tregs in experimental atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2007, 27(4):893-900.
11. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ Tregs. Nat. Immunol. 2003, 4(4):330-336.
12. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science (New York, NY) 2003, 299(5609):1057-1061.
13. Mallat Z., Gojova A., Brun V., Esposito B., Fournier N., Cottrez F., et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003, 108(10):1232-1237.
14. Chang H.K., Shin M.S., Yang H.Y., Lee J.W., Kim Y.S., Lee M.H., et al. Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells. Biol. Pharm. Bull. 2006, 29(8):1597-1602.
15. Laster W.R., Schabel F.M. Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056). Cancer Chemother. Rep. 1975, 59(5):951-965.
16. Milazzo S., Lejeune S., Ernst E. Laetrile for cancer: a systematic review of the clinical evidence. Support. Care Cancer 2007, 15(6):583-595.
17. Heikkila R.E., Cabbat F.S. The prevention of alloxan-induced diabetes by amygdalin. Life Sci. 1980, 27(8):659-662.
18. Baroni A., Paoletti I., Greco R., Satriano R.A., Ruocco E., Tufano M.A., et al. Immunomodulatory effects of a set of amygdalin analogues on human keratinocyte cells. Exp. Dermatol. 2005, 14(11):854-859.
19. Hwang H.J., Lee H.J., Kim C.J., Shim I., Hahm D.H. Inhibitory effect of amygdalin on lipopolysaccharide-inducible TNF-alpha and IL-1beta mRNA expression and carrageenan-induced rat arthritis. J. Microbiol. Biotechnol. 2008, 18(10):1641-1647.
20. Nabel E.G., Ganz P., Gordon J.B., Alexander R.W., Selwyn A.P. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 1988, 77(1):43-52.
21. Antony I., Aptecar E., Lerebours G., Nitenberg A. Coronary artery constriction caused by the cold pressor test in human hypertension. Hypertension 1994, 24(2):212-219.
22. Antony I., Lerebours G., Nitenberg A. Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients. Circulation 1996, 94(12):3115-3122.
23. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71(2):343-353.
24. George J., Harats D., Gilburd B., Afek A., Shaish A., Kopolovic J., et al. Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 2000, 102(15):1822-1827.
25. George J., Afek A., Gilburd B., Shoenfeld Y., Harats D. Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J. Am. Coll. Cardiol. 2001, 38(3):900-905.
26. Cobbold S.P., Castejon R., Adams E., Zelenika D., Graca L., Humm S., et al. Induction of Foxp3+ Tregs in the periphery of T cell receptor transgenic mice tolerized to transplants. J. Immunol. 2004, 172(10):6003-6010.
27. Gondek D.C., Lu L.F., Quezada S.A., Sakaguchi S., Noelle R.J. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 2005, 174(4):1783-1786.
28. Zhou X., Nicoletti A., Elhage R., Hansson G.K. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000, 102(24):2919-2922.
29. Steffens S., Burger F., Pelli G., Dean Y., Elson G., Kosco-Vilbois M., et al. Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice. Circulation 2006, 114(18):1977-1984.
30. van Puijvelde G.H., Hauer A.D., de Vos P., van den Heuvel R., van Herwijnen M.J., van der Zee R., et al. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation 2006, 114(18):1968-1976.
31. Belghith M., Bluestone J.A., Barriot S., Megret J., Bach J.F., Chatenoud L. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 2003, 9(9):1202-1208.
32. Akbari O., DeKruyff R.H., Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2001, 2(8):725-731.
33. Ochs H.D., Ziegler S.F., Torgerson T.R. FOXP3 acts as a rheostat of the immune response. Immunol. Rev. 2005, 203:156-164.
34. Mor A., Luboshits G., Planer D., Keren G., George J. Altered status of CD4(+)CD25(+) Tregs in patients with acute coronary syndromes. Eur. Heart J. 2006, 27(21):2530-2537.
35. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001, 27(1):68-73.